We are happy to invite you to our next webinar! Date: 21st of March 2018 Time: 3:00pm (GMT+2) Foods for Special Medical Purposes (FSMPs) are intended for the exclusive or partial feeding of people whose nutritional requirements cannot be met by normal foods. They can only be used under medical supervision. They are regulated under (EU) No 609/2013 [...]
About Emilie-Marie VieubleThis author has not yet filled in any details.
So far Emilie-Marie Vieuble has created 54 blog entries.
FSMP and innovation in infant nutrition. New a&r innovation scouting service available. Next webinar!
a&r’s News Digest – We dedicate this month’s issue to FSMP and innovation in infant nutrition. New innovation scouting service available from a&r – see below! […]
EFSA updated scientific guidance for health claims on antioxidants, oxidative damage and cardiovascular health During this month, EFSA published the final guidance on the scientific requirements for health claims related to antioxidants, oxidative damage, and cardiovascular health. This guidance replaces the one from 2011. The guidance supports applicants in the preparation of their applications [...]
The excessive intake of vitamins and minerals may result in adverse effects and therefore official bodies deem it necessary to set maximum safe levels for them in food supplements. The Directive 2002/46/EC on food supplements envisages the setting of maximum and minimum amounts of vitamins and minerals in supplements. Although, in recent years, different [...]
The new Novel Foods Regulation ((EU) 2015/2283) went live on January 1, 2018. Its aim is to improve the conditions of food business operators bringing new and innovative foods to the EU market while maintaining a high level of food safety for European consumers. The new Regulation replaces the former system of national authorizations for a simple, [...]
An overview on the Novel Foods Regulation and New recommendations on maximum levels of vitamins and minerals in Germany
a&r’s News Digest – We dedicate this month's issue to an overview on the Novel Foods Regulation and the new recommendations on maximum levels of vitamins and minerals in Germany. SUBSCRIBE Regulatory News Novel foods regulation overview The new Novel Foods Regulation ((EU) 2015/2283) went live [...]
It has been reported by Bloomberg that Nestle is currently the top bidder for Merck KGaA’s, offering up to $5 billion. According to the sources, companies previously interested in this business have dropped out of the bidding, including Perrigo and Bain and Cinven, while Reckitt Benckiser and Mylan are still in the running. Nestle, frontrunner [...]
GSK has declared that they are looking at Pfizer consumer healthcare, but this not a business priority. Pfizer’s consumer division has been for sale since last year. It includes well-known brands such as Advil, Chapstick lip balm, and Centrum vitamins, and it could cost more than $15 billion.
Global ingredients company DSM has acquired Biocare Copenhagen, expanding their gut health portfolio for an undisclosed price. With this acquisition, DSM will increase its gut health portfolio with probiotics. The company has showed interest in gut health ingredients beyond the well-known indications for digestive and immune health.
Walgreens has announced that it will invest $416 million to acquire 40% stake in Sinopharm Holding GuoDa Drug Store Co., Ltd (GuoDa). Walgreens is the second-largest pharmacy store chain in the US behind CVS Health. GuoDa retails pharmaceutical and healthcare products across China. Walgreens was already present in China through Alliance Boots. This new investment [...]